Changes in Beneficial Ownership · 4
iRadimed Corporation
IRMDNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1782221342.xml
Filing details
- Report period
- 2026-06-20
- Issuer
- IRADIMED CORP
- Issuer CIK
- 0001325618
- Trading symbol
- IRMD
Reporting owner 1
- Name
- GLENN JOHN
- Reporting owner CIK
- 0001253497
- Relationship
- Officer
- Officer title
- CFO
- Address
- C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO, FL, 32826
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-06-20 | M · Form 4 | 5,796[F1] | A | [F1] | 14,256 | D |
| Common Stock | 2026-06-20 | F · Form 4 | 2,319 | D | 92.20 | 11,937 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- F · Form 4
- Securities delivered or withheld for exercise price or tax liability under Rule 16b-3
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units | [F1] | 2026-06-20 | M · Form 4 | 5,796 | D | 0 | [F2] | [F2] | Common Stock | 5,796 | 0 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
- F1
- Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.↩ 1↩ 2↩ 3
- F2
- The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 30, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.↩ 1↩ 2
Signature 1
- Signed
- /s/ John Glenn
- Date
- 2026-06-23
Company context
IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is essential to critically ill patients who cannot be removed from their vital medications and children and infants who must generally be sedated to remain immobile during an MRI scan.